Via InvestorWireIBN a multifaceted financial news and publishing company, today announces that it will be collaborating with Microdose Psychedelic Insights for the Psych e delic Capital: October 2021 Conference which is set to be held in an entirely virtual format on Oct. 28, 2021. The Psychedelic Capital: October Conference is set to be a virtual event, covering the most innovative and cutting-edge companies, ...

Via InvestorWireIBN ("InvestorBrandNetwork"), a multifaceted financial news and publishing company, today announces that it will be collaborating with Microdose Psychedelic Insights for the Psych e delic Capital: October 2021 Conference which is set to be held in an entirely virtual format on Oct. 28, 2021.

The Psychedelic Capital: October Conference is set to be a virtual event, covering the most innovative and cutting-edge companies, latest IPOs, newest opportunities and deepest insights into the global psychedelic industry. From exploring ongoing governmental policy shifts to commercial product breakthroughs, the conference will serve to educate attendees on the potential uses and benefits attached to psychedelics in today's environment.

Forming part of an investor conference series diving deep into the psychedelics industry, the Psychedelic Capital Conference will play host to a series of corporate presentations, which will include Numinus Wellness (TSX-V: NUMI), a company focused on developing and delivering transformative, proprietary psychedelic therapeutics that are inspired by tradition and informed by science. The event will also feature an investor roundtable seeking to address some of the pressing issues affecting the global psychedelics industry.

Alongside IBN, PsychedelicNewsWire ("PNW"), in its capacity as an official media sponsor, will further the distribution of content generated for the event to enthusiasts within the psychedelics space.

"IBN, alongside its PsychedelicNewsWire brand, is pleased to be collaborating once again with Microdose Psychedelic Insights," states Jonathan Keim, communications director for IBN. "We will leverage our communications solutions to heighten visibility in advance of the event and also widen the reach to additional investor audiences through real-time coverage."

IBN will be providing the event with amplified article syndication to more than 5,000 strategic syndication partners, extended social media coverage through a variety of investor-oriented accounts that collectively reach 2 million+ likes and followers, as well as feature the conference on dedicated event pages.

"We are pleased to once again collaborate with the IBN and PNW teams," comments Patrick Moher, CEO of Microdose. "Their powerful tools and communication solutions create a robust online presence, which strengthens the valuable connections our team creates between executives and investors. We are excited to be hosting the Psychedelic Capital Conference as part of a series of events designed to drive the psychedelics industry into the forefront of modern medicine, and we believe that IBN's assistance in helping us reach a broader investor audience will continue to be invaluable."

About Microdose Psychedelics Insights

Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world's perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine.

About IBN

IBN (InvestorBrandNetwork) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through NetworkNewsWire ("NNW") and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.

For more information, please visit https://www.InvestorBrandNetwork.com .

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://IBN.fm/Disclaimer

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less
AgriFORCE

AgriFORCE Signs Definitive Contract to Deploy Its Proprietary Grow House Facility and IP in Barbados for Production of High Value Medical and Agricultural Crops

AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ: AGRI; AGRIW), an Intellectual Property (IP) -focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple platforms, has signed a definitive contract with Humboldt Bliss, Ltd. (“Humboldt”), an agriculture and aquaculture business based in Barbados, West Indies. The contract is for the deployment of the AgriFORCE foundational IP – which includes a proprietary facility design, production and operation technologies and methods, and an automated growing system (the AgriFORCE “Grow House”) for the cultivation and sale of high value medical and agricultural products into the Caribbean and global pharmaceutical and agricultural markets.

Keep reading... Show less
Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE:3ZQ0 ) (the "Company" or "Ayurcann") a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has won Extraction Facility of the Year and Toll Processing Facility of the Year at the 2021 GrowUp Awards Gala in Niagara Falls, Ontario, Canada.

Ayurcann is a growing extraction company continuously incorporating new and strategic business approaches to maintain their industry leading services. With an annual extraction capacity of up to 300,000 kg, Ayurcann can supply bulk or formulated THC and CBD products to industry leaders while also offering a competitive advantage through their white labelling services.

Keep reading... Show less
Adastra Holdings Reports Record Third Quarter Results

Adastra Holdings Reports Record Third Quarter Results

 Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") has today filed its consolidated financial statements and related management discussion and analysis for the three and nine months ended September 30, 2021 and 2020, both of which are available at www.sedar.com .

Keep reading... Show less
AgriFORCE Signs Definitive Contract to Deploy Its Proprietary Grow House Facility and IP in Barbados for Production of High Value Medical and Agricultural Crops

AgriFORCE Signs Definitive Contract to Deploy Its Proprietary Grow House Facility and IP in Barbados for Production of High Value Medical and Agricultural Crops

Focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple platforms, has signed a definitive contract with Humboldt Bliss, Ltd. ("Humboldt"), an agriculture and aquaculture business based in Barbados, West Indies. The contract is for the deployment of the AgriFORCE foundational IP which includes a proprietary facility design, production and operation technologies and methods, and an automated growing system (the AgriFORCE "Grow House") for the cultivation and sale of high value medical and agricultural products into the Caribbean and global pharmaceutical and agricultural markets.

Under the terms of the contract, AgriFORCE is responsible for constructing its proprietary facility and providing the full Standard Operating Procedures (SOPs) of the AgriFORCE Grow House and Humboldt is responsible for securing the project's land as well as operating the facility. Upon production, Humboldt has committed to remit an IP licensing, management services and equipment leasing fee to AgriFORCE for up to 14,300 pounds (6,500 kgs) of high value medical and agricultural crops per year. Based on AgriFORCE's internal financial modelling and current market index pricing, the Company believes that the contract represents $12.7M of annual recurring EBITDA. 1 As the initial contract is for a five-year-term, the Company believes this represents more than $63M in EBITDA 1 over the initial term and with two five-year automatic renewals, it anticipates the total contract EBITDA 1 could be up to approximately $190 million. The contract will be backed by a rolling $5 million performance bond maintained by Humboldt.

Keep reading... Show less
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Greenrose Acquisition Corp. - GNRS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Greenrose Acquisition Corp. - GNRS

Pomerantz LLP is investigating claims on behalf of investors of Greenrose Acquisition Corp. ("Greenrose" or the "Company") (OTCMKTS: GNRS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Greenrose and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Keep reading... Show less

Top News

Related News